BCL2L1 and cancer: Although increased priming correlated with increased sensitivity to BCL-2/BCL-xL inhibition in certain contexts, TIS cancer cells generally exhibited similar or reduced overall priming compared to their proliferative counterparts, revealing a nuanced apoptotic landscape.